LESUN Pharma, established in 2011, is a dual-core-driven international pharmaceutical company. It is devoted to discovering next-generation anti-cancer therapeutics for the purpose of improving the lives of people living with cancer.
The founder, Prof. Shudong Wang, CSO, is the Head of Drug Discovery and Development pharmaceutical center, University of South Australia. She has demonstrated sustained translational research that is highlighted by a portfolio of over 90 patent applications, and has achieved extensive success in commercialisation from her research.
Now, two drug candidates (QHRD 107 and QHRD 110) are under clinical development. The relevant patent rights in China have been licensed to Changzhou Qianhong Bio-Pharma Co. Ltd in the territory of China mainland.
